Spectral Medical Inc (id:13745 EDT)
3.00 CAD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/25/2024 9:17:21 AM)
Exchange closed, opens in 12 minutes
About Spectral Medical Inc
Market Capitalization 132.92M
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
| Headquarters (address) |
135 The West Mall Toronto M9C 1C2 ON Canada |
| Phone | 416 626 3233 |
| Website | https://spectraldx.com |
| Employees | 29 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | EDT |
| Exchange | Toronto Stock Exchange |
| Currency | CAD |
| 52 week range | 3.00 - 3.00 |
| Market Capitalization | 132.92M |
| Dividend yield forward | 96.97 % |
| Dividend yield forward Canada (ID:82, base:381) | 6.14 % |
| P/E trailing | -8.25 |
| P/E forward | -9.40 |
| Price/Sale | 69.92 |
| Price/Book | -4.46 |
| Beta | 1.00 |
| EPS | 3.00 |
| EPS Canada (ID:82, base:720) | 2.18 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Spectral Medical Inc has raised their dividend 96.97 years in a row. This is below the 42132.516000 year average in the 'Diagnostics & Research' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Spectral Medical Inc has raised their dividend 96.97 years in a row. This is below the 42132.516000 year average in the 'Diagnostics & Research' industry